Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury

David J. Kaczorowski, Atsunori Nakao, Kenneth R. McCurry, Timothy R. Billiar

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Cardiac ischemia/reperfusion (I/R) injury occurs in several important clinical contexts including percutaneous coronary interventions for acute myocardial ischemia, cardiac surgery in the setting of cardiopulmonary bypass, and cardiac transplantation. While the pathogenesis of I/R injury in these settings is multifactorial, it is clear that activation of the innate immune system and the resultant inflammatory response are important components of I/R injury. Toll-like receptor 4 (TLR4), originally identified as the sensor for bacterial lipopolysaccharide (LPS), has also been shown to serve as a sensor for endogenous molecules released from damaged or ischemic tissues. Accordingly, recent findings have demonstrated that TLR4 not only plays a central role as a mediator of cardiac dysfunction in sepsis, but also serves as a key mediator of myocardial injury and inflammation in the setting of I/R. Furthermore, TLR4 may play a role in the development of atherosclerotic lesions. Other studies have implicated TLR4 in the adverse remodeling that may occur after ischemic myocardial injury. This emerging body of literature, which is reviewed here, has provided new insight into the early molecular events that mediate myocardial injury and dysfunction in the setting of I/R injury.

Original languageEnglish
Pages (from-to)196-202
Number of pages7
JournalCurrent Cardiology Reviews
Volume5
Issue number3
DOIs
Publication statusPublished - Aug 2009
Externally publishedYes

Fingerprint

Myocardial Reperfusion
Toll-Like Receptor 4
Toll-Like Receptors
Reperfusion Injury
Myocardial Ischemia
Inflammation
Wounds and Injuries
Percutaneous Coronary Intervention
Heart Transplantation
Cardiopulmonary Bypass
Thoracic Surgery
Lipopolysaccharides
Immune System
Sepsis

Keywords

  • Heart
  • Inflammation
  • Ischemia/reperfusion
  • Toll-like receptors
  • Transplant

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury. / Kaczorowski, David J.; Nakao, Atsunori; McCurry, Kenneth R.; Billiar, Timothy R.

In: Current Cardiology Reviews, Vol. 5, No. 3, 08.2009, p. 196-202.

Research output: Contribution to journalReview article

Kaczorowski, David J. ; Nakao, Atsunori ; McCurry, Kenneth R. ; Billiar, Timothy R. / Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury. In: Current Cardiology Reviews. 2009 ; Vol. 5, No. 3. pp. 196-202.
@article{39053959b7c04e588fc23b97d867b630,
title = "Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury",
abstract = "Cardiac ischemia/reperfusion (I/R) injury occurs in several important clinical contexts including percutaneous coronary interventions for acute myocardial ischemia, cardiac surgery in the setting of cardiopulmonary bypass, and cardiac transplantation. While the pathogenesis of I/R injury in these settings is multifactorial, it is clear that activation of the innate immune system and the resultant inflammatory response are important components of I/R injury. Toll-like receptor 4 (TLR4), originally identified as the sensor for bacterial lipopolysaccharide (LPS), has also been shown to serve as a sensor for endogenous molecules released from damaged or ischemic tissues. Accordingly, recent findings have demonstrated that TLR4 not only plays a central role as a mediator of cardiac dysfunction in sepsis, but also serves as a key mediator of myocardial injury and inflammation in the setting of I/R. Furthermore, TLR4 may play a role in the development of atherosclerotic lesions. Other studies have implicated TLR4 in the adverse remodeling that may occur after ischemic myocardial injury. This emerging body of literature, which is reviewed here, has provided new insight into the early molecular events that mediate myocardial injury and dysfunction in the setting of I/R injury.",
keywords = "Heart, Inflammation, Ischemia/reperfusion, Toll-like receptors, Transplant",
author = "Kaczorowski, {David J.} and Atsunori Nakao and McCurry, {Kenneth R.} and Billiar, {Timothy R.}",
year = "2009",
month = "8",
doi = "10.2174/157340309788970405",
language = "English",
volume = "5",
pages = "196--202",
journal = "Current Cardiology Reviews",
issn = "1573-403X",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury

AU - Kaczorowski, David J.

AU - Nakao, Atsunori

AU - McCurry, Kenneth R.

AU - Billiar, Timothy R.

PY - 2009/8

Y1 - 2009/8

N2 - Cardiac ischemia/reperfusion (I/R) injury occurs in several important clinical contexts including percutaneous coronary interventions for acute myocardial ischemia, cardiac surgery in the setting of cardiopulmonary bypass, and cardiac transplantation. While the pathogenesis of I/R injury in these settings is multifactorial, it is clear that activation of the innate immune system and the resultant inflammatory response are important components of I/R injury. Toll-like receptor 4 (TLR4), originally identified as the sensor for bacterial lipopolysaccharide (LPS), has also been shown to serve as a sensor for endogenous molecules released from damaged or ischemic tissues. Accordingly, recent findings have demonstrated that TLR4 not only plays a central role as a mediator of cardiac dysfunction in sepsis, but also serves as a key mediator of myocardial injury and inflammation in the setting of I/R. Furthermore, TLR4 may play a role in the development of atherosclerotic lesions. Other studies have implicated TLR4 in the adverse remodeling that may occur after ischemic myocardial injury. This emerging body of literature, which is reviewed here, has provided new insight into the early molecular events that mediate myocardial injury and dysfunction in the setting of I/R injury.

AB - Cardiac ischemia/reperfusion (I/R) injury occurs in several important clinical contexts including percutaneous coronary interventions for acute myocardial ischemia, cardiac surgery in the setting of cardiopulmonary bypass, and cardiac transplantation. While the pathogenesis of I/R injury in these settings is multifactorial, it is clear that activation of the innate immune system and the resultant inflammatory response are important components of I/R injury. Toll-like receptor 4 (TLR4), originally identified as the sensor for bacterial lipopolysaccharide (LPS), has also been shown to serve as a sensor for endogenous molecules released from damaged or ischemic tissues. Accordingly, recent findings have demonstrated that TLR4 not only plays a central role as a mediator of cardiac dysfunction in sepsis, but also serves as a key mediator of myocardial injury and inflammation in the setting of I/R. Furthermore, TLR4 may play a role in the development of atherosclerotic lesions. Other studies have implicated TLR4 in the adverse remodeling that may occur after ischemic myocardial injury. This emerging body of literature, which is reviewed here, has provided new insight into the early molecular events that mediate myocardial injury and dysfunction in the setting of I/R injury.

KW - Heart

KW - Inflammation

KW - Ischemia/reperfusion

KW - Toll-like receptors

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=70449672968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449672968&partnerID=8YFLogxK

U2 - 10.2174/157340309788970405

DO - 10.2174/157340309788970405

M3 - Review article

C2 - 20676278

AN - SCOPUS:70449672968

VL - 5

SP - 196

EP - 202

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

SN - 1573-403X

IS - 3

ER -